Pain Education and Therapeutic Exercise for Fibromyalgia
Effects of Pain Education and Therapeutic Exercise for Patients With Fibromyalgia
1 other identifier
interventional
32
1 country
1
Brief Summary
Fibromyalgia syndrome is characterized by chronic generalized musculoskeletal pain associated with fatigue, sleep disturbances and psychological problems. The European League Againts Rheumatism (EULAR) described an algorithm how to treat step by step these patients. The objective of this trial is to evaluate if patient education plus therapeutic exercise is more effective in pain intensity, fatigue, function, strength, pain threshold, anxiety, depression, quality of life, quality of sleep, kinesiophobia, pain coping and biochemical and genetic markers and compared to therapeutic exercise. For this purpose the investigators conduct a randomized controlled trial double-blind (patient and examiner). The investigators included patients diagnosed of fibromyalgia according to the American College of Rheumatology (ACR). Patients included are randomized into 2 groups one receive education of pain neurophysiology plus exercise therapy and the other only exercise therapy. Groups receive 3 treatment sessions a week over 10 weeks. The variables are measured at the beginning and end of treatment. And also some variables are measured before and after each session.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 16, 2018
CompletedFirst Posted
Study publicly available on registry
August 22, 2018
CompletedStudy Start
First participant enrolled
September 3, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2019
CompletedMarch 26, 2021
March 1, 2021
5 months
August 16, 2018
March 23, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Pain Intensity: VAS
The investigators measure the intensity of pain with a Visual Analogic Scale (VAS) pre-intervention at baseline
Baseline
Pain Intensity: VAS
The investigators measure the intensity of pain with a Visual Analogic Scale (VAS) at the end of the intervention
through study completion, an average 10 weeks
Fibromyalgia Impact Questionnaire
The investigators measure the impact of Fibromyalgia syndrome by Fibromyalgia Impact Questionnaire R (FIQ-R) pre-intervention at baseline
Baseline
Fibromyalgia Impact Questionnaire
The investigators measure the impact of Fibromyalgia syndrome by Fibromyalgia Impact Questionnaire R (FIQ-R) at the end of the intervention
through study completion, an average 10 weeks
Secondary Outcomes (18)
Fatigue
Baseline
Fatigue
through study completion, an average 10 weeks
Quality of Sleep
Baseline
Quality of Sleep: Pittsburg Sleeping Questionnaire
through study completion, an average 10 weeks
Functional Capacity
Baseline
- +13 more secondary outcomes
Study Arms (2)
Pain education plus exercise therapy (PE + ET)
EXPERIMENTALPain education according to the book "Explain Pain" written by Lorimer Moseley and David Butler Exercise therapy based primarily in aerobic exercise according clinical guidelines last recommendations.
Exercise therapy (ET)
ACTIVE COMPARATORExercise therapy based primarily in aerobic exercise according clinical guidelines last recommendations.
Interventions
To explain the physiology of nervous system and the mechanism and modulation of acute and chronic pain. To perform different whole body aerobic exercises with a mild to moderate intensity according to Borg scale and maximum heart rate.
To perform different whole body aerobic exercises with a mild to moderate intensity according to Borg scale and maximum heart rate.
Eligibility Criteria
You may qualify if:
- Diagnosed medically with Fibromyalgia
- Diagnosed according to the American College of Rheumatology criteria
- Agreement to attend to treatment sessions
You may not qualify if:
- Any kind of contraindications for physical activity
- Other kind of diseases that could limit the intervention
- Previous surgery last year
- Medication modifications in the last 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad de Zaragozalead
- University of Valladolidcollaborator
Study Sites (1)
Sandra Jiménez del Barrio
Soria, 42004, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 16, 2018
First Posted
August 22, 2018
Study Start
September 3, 2018
Primary Completion
January 30, 2019
Study Completion
January 30, 2019
Last Updated
March 26, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share
The patient data were confidential and were assigned a number to each patient to maintain confidentiality